6 Up to 40% of the weight people lose on GLP-1s is lean muscle mass, not fat
In gastroparesis, food may sit in the stomach for hours, causing severe bloating, nausea, vomiting, and malnutrition
10S12S25
Here's what Found's program is built on: - Lower doses of GLP-1s provide metabolic benefits with improved tolerability (Nature, 2025) - 94% reduction in diabetes progression in people with prediabetes (NEJM, 2017) - Improved insulin sensitivity in PCOS (Reproductive Sciences, 2022) - Cardiovascular benefits independent of weight (Annals of Internal Medicine, 2024) - Reduction in systemic inflammation (Cells, 2024) Our approach: Apply these research insights to early intervention, informed also by clinical practice and real-world patient outcomes
Pre-existing gastrointestinal disorders, particularly functional dyspepsia or irritable bowel syndrome, appear to predispose patients to more pronounced GI symptoms